Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-156599
Filing Date
2023-05-30
Accepted
2023-05-30 16:18:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d468536d424b5.htm 424B5 339783
2 GRAPHIC g468536g00g01.jpg GRAPHIC 47155
3 GRAPHIC g468536g04s40.jpg GRAPHIC 43627
4 GRAPHIC g468536g17p96.jpg GRAPHIC 71469
  Complete submission text file 0001193125-23-156599.txt   564797
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267221 | Film No.: 23976662
SIC: 2834 Pharmaceutical Preparations